Concepedia

Steven D. Linton

SD

Statistics

Publications

8

Citations

298

H-Index

8

Active since

1990

Affiliations

Idera Pharmaceuticals (United States)(Current)

Novartis (Switzerland)

Rice University

Steven D. Linton is an author at Idera Pharmaceuticals (United States) specializing in drug discovery, pharmacy, and apoptosis.

Publications per year

1990–2005

8

Publications

8

First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease

Steven D. Linton, Teresa Aja, Robert A. Armstrong et al. · Journal of Medicinal Chemistry · 2005 · 106 citations

, , +14

Conformationally constrained inhibitors of caspase-1 (interleukin-1β converting enzyme) and of the human ced-3 homologue caspase-3 (CPP32, apopain)

Donald S. Karanewsky, Xu Bai, Steven D. Linton et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 42 citations · Full text

, , +7

Total synthesis of (+)-porothramycin B

Tohru Fukuyama, Gang Liu, Steven D. Linton et al. · Tetrahedron Letters · 1993 · 34 citations

, , +3

Acyl dipeptides as reversible caspase inhibitors. Part 1: Initial Lead Optimization

Steven D. Linton, Donald S. Karanewsky, Robert J. Ternansky et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 33 citations · Full text

, , +13

A stereocontrolled total synthesis of (±)-renieramycin A

Tohru Fukuyama, Steven D. Linton, Min Min Tun · Tetrahedron Letters · 1990 · 32 citations

, , +11

1–5 of 8